AngioDynamics SEC Filings
NASDAQ: ANGOHealth CareMedical/Dental InstrumentsUSD
11.52+0.29 (+2.58%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AngioDynamics filing overview
This page lists 3 recent SEC filings by AngioDynamics (ANGO), including 2 8-K, 1 10-Q. The most recent quarterly report (10-Q) was filed on Oct 8, 2026. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 8, 2026.
Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
ANGO SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 8, 2026 | 8-K | Entry into a Material Definitive Agreement; Departure or Appointment of Directors or Officers; Compensatory Arrangements | View on EDGAR |
| Oct 8, 2026 | 8-K | Results of Operations and Financial Condition; Regulation FD Disclosure | View on EDGAR |
| Oct 8, 2026 | 10-Q | Quarterly report | View on EDGAR |